These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

848 related articles for article (PubMed ID: 32706339)

  • 1. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis.
    Wilson JG; Simpson LJ; Ferreira AM; Rustagi A; Roque J; Asuni A; Ranganath T; Grant PM; Subramanian A; Rosenberg-Hasson Y; Maecker HT; Holmes SP; Levitt JE; Blish CA; Rogers AJ
    JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32706339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction.
    Wang J; Yang X; Li Y; Huang JA; Jiang J; Su N
    Virol J; 2021 Jun; 18(1):117. PubMed ID: 34088317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the Inflammatory Response to Severe COVID-19 Illness.
    McElvaney OJ; McEvoy NL; McElvaney OF; Carroll TP; Murphy MP; Dunlea DM; Ní Choileáin O; Clarke J; O'Connor E; Hogan G; Ryan D; Sulaiman I; Gunaratnam C; Branagan P; O'Brien ME; Morgan RK; Costello RW; Hurley K; Walsh S; de Barra E; McNally C; McConkey S; Boland F; Galvin S; Kiernan F; O'Rourke J; Dwyer R; Power M; Geoghegan P; Larkin C; O'Leary RA; Freeman J; Gaffney A; Marsh B; Curley GF; McElvaney NG
    Am J Respir Crit Care Med; 2020 Sep; 202(6):812-821. PubMed ID: 32584597
    [No Abstract]   [Full Text] [Related]  

  • 4. Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease.
    Zhao Y; Qin L; Zhang P; Li K; Liang L; Sun J; Xu B; Dai Y; Li X; Zhang C; Peng Y; Feng Y; Li A; Hu Z; Xiang H; Ogg G; Ho LP; McMichael A; Jin R; Knight JC; Dong T; Zhang Y
    JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32501293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of the TNF-Related Cytokine LIGHT Increase in Hospitalized COVID-19 Patients with Cytokine Release Syndrome and ARDS.
    Perlin DS; Zafir-Lavie I; Roadcap L; Raines S; Ware CF; Neil GA
    mSphere; 2020 Aug; 5(4):. PubMed ID: 32817460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An inflammatory cytokine signature predicts COVID-19 severity and survival.
    Del Valle DM; Kim-Schulze S; Huang HH; Beckmann ND; Nirenberg S; Wang B; Lavin Y; Swartz TH; Madduri D; Stock A; Marron TU; Xie H; Patel M; Tuballes K; Van Oekelen O; Rahman A; Kovatch P; Aberg JA; Schadt E; Jagannath S; Mazumdar M; Charney AW; Firpo-Betancourt A; Mendu DR; Jhang J; Reich D; Sigel K; Cordon-Cardo C; Feldmann M; Parekh S; Merad M; Gnjatic S
    Nat Med; 2020 Oct; 26(10):1636-1643. PubMed ID: 32839624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections.
    Remy KE; Mazer M; Striker DA; Ellebedy AH; Walton AH; Unsinger J; Blood TM; Mudd PA; Yi DJ; Mannion DA; Osborne DF; Martin RS; Anand NJ; Bosanquet JP; Blood J; Drewry AM; Caldwell CC; Turnbull IR; Brakenridge SC; Moldwawer LL; Hotchkiss RS
    JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32687484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.
    Han H; Ma Q; Li C; Liu R; Zhao L; Wang W; Zhang P; Liu X; Gao G; Liu F; Jiang Y; Cheng X; Zhu C; Xia Y
    Emerg Microbes Infect; 2020 Dec; 9(1):1123-1130. PubMed ID: 32475230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019.
    Huang L; Zhao X; Qi Y; Li H; Ye G; Liu Y; Zhang Y; Gou J
    Cell Mol Immunol; 2020 Oct; 17(10):1092-1094. PubMed ID: 32917983
    [No Abstract]   [Full Text] [Related]  

  • 10. IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome.
    Kang S; Tanaka T; Inoue H; Ono C; Hashimoto S; Kioi Y; Matsumoto H; Matsuura H; Matsubara T; Shimizu K; Ogura H; Matsuura Y; Kishimoto T
    Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22351-22356. PubMed ID: 32826331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
    Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
    Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of the Appropriate Control Group Is Essential in Evaluating the Cytokine Storm in COVID-19.
    Vassiliou AG; Dimopoulou I; Jahaj E; Keskinidou C; Mastora Z; Orfanos SE; Kotanidou A
    In Vivo; 2021; 35(2):1295-1298. PubMed ID: 33622933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time.
    Meduri GU; Headley S; Kohler G; Stentz F; Tolley E; Umberger R; Leeper K
    Chest; 1995 Apr; 107(4):1062-73. PubMed ID: 7705118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response.
    Arnaldez FI; O'Day SJ; Drake CG; Fox BA; Fu B; Urba WJ; Montesarchio V; Weber JS; Wei H; Wigginton JM; Ascierto PA
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32385146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-17A and TNF-α as potential biomarkers for acute respiratory distress syndrome and mortality in patients with obesity and COVID-19.
    Leija-Martínez JJ; Huang F; Del-Río-Navarro BE; Sanchéz-Muñoz F; Muñoz-Hernández O; Giacoman-Martínez A; Hall-Mondragon MS; Espinosa-Velazquez D
    Med Hypotheses; 2020 Nov; 144():109935. PubMed ID: 32795834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
    Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
    JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019.
    Chen X; Zhao B; Qu Y; Chen Y; Xiong J; Feng Y; Men D; Huang Q; Liu Y; Yang B; Ding J; Li F
    Clin Infect Dis; 2020 Nov; 71(8):1937-1942. PubMed ID: 32301997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definition and Risks of Cytokine Release Syndrome in 11 Critically Ill COVID-19 Patients With Pneumonia: Analysis of Disease Characteristics.
    Wang W; Liu X; Wu S; Chen S; Li Y; Nong L; Lie P; Huang L; Cheng L; Lin Y; He J
    J Infect Dis; 2020 Oct; 222(9):1444-1451. PubMed ID: 32601708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Cytokine Storm in COVID-19 Patients With Immunomodulatory Therapy.
    Yessayan L; Szamosfalvi B; Napolitano L; Singer B; Kurabayashi K; Song Y; Westover A; Humes HD
    ASAIO J; 2020; 66(10):1079-1083. PubMed ID: 33136592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An inter-correlated cytokine network identified at the center of cytokine storm predicted COVID-19 prognosis.
    Liu Y; Chen D; Hou J; Li H; Cao D; Guo M; Ling Y; Gao M; Zhou Y; Wan Y; Zhu Z
    Cytokine; 2021 Feb; 138():155365. PubMed ID: 33246770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.